• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙肝病毒X抗原(HBxAg)与慢性感染及肝癌发生中的细胞周期调控

Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis.

作者信息

Feitelson Mark Alan, Reis Helena M G P V, Liu Jie, Lian Zhaorui, Pan Jingbo

机构信息

Department of Pathology, Anatomy and Cell Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.

出版信息

Front Biosci. 2005 May 1;10:1558-72. doi: 10.2741/1640.

DOI:10.2741/1640
PMID:15769646
Abstract

Hepatitis B and related viruses that infect mammalian hosts encode the "X" protein that has been shown to contribute importantly to the pathogenesis of chronic liver disease (CLD) and to the development of hepatocellular carcinoma (HCC). In a variety of tissue culture systems, hepatitis B virus (HBV) X antigen, or HBxAg, has been shown to trigger apoptosis, while other evidence suggests that HBxAg inhibits apoptosis and stimulates the cell cycle by constitutively activating a number of signaling pathways that are important for hepatocellular growth and survival. These apparently contrasting properties of HBxAg may be associated with differences in the X protein itself, since carboxy-terminal truncated forms of HBxAg appear to be associated with HCC lesions. Alternatively, or in addition, these differences may be due to the cell type, state of cell differentiation, and whether expression occurs in resting or dividing cells. Further, the association between HBxAg expression and chromosomal instability, may also contribute to the apparently contrasting fates of HBxAg positive cells. It is proposed that in many of these systems, the different outcomes of HBxAg expression may be due to the nature of the cellular response to HBxAg, and not due to differences in the fundamental properties of HBxAg, the latter of which promote cell survival, cell cycle progression, and the development of HCC.

摘要

感染哺乳动物宿主的乙型肝炎及相关病毒编码“X”蛋白,该蛋白已被证明对慢性肝病(CLD)的发病机制以及肝细胞癌(HCC)的发展起着重要作用。在多种组织培养系统中,乙型肝炎病毒(HBV)X抗原,即HBxAg,已被证明可引发细胞凋亡,而其他证据表明,HBxAg可抑制细胞凋亡并通过持续激活一些对肝细胞生长和存活至关重要的信号通路来刺激细胞周期。HBxAg这些明显相反的特性可能与X蛋白本身的差异有关,因为HBxAg的羧基末端截短形式似乎与HCC病变有关。或者,或者此外,这些差异可能是由于细胞类型、细胞分化状态以及表达是发生在静止细胞还是分裂细胞中。此外,HBxAg表达与染色体不稳定性之间的关联,也可能导致HBxAg阳性细胞明显不同的命运。有人提出,在许多这些系统中,HBxAg表达的不同结果可能是由于细胞对HBxAg的反应性质,而不是由于HBxAg基本特性的差异,后者促进细胞存活、细胞周期进展以及HCC的发展。

相似文献

1
Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis.乙肝病毒X抗原(HBxAg)与慢性感染及肝癌发生中的细胞周期调控
Front Biosci. 2005 May 1;10:1558-72. doi: 10.2741/1640.
2
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.乙型肝炎病毒X抗原在慢性感染发病机制及肝细胞癌发生发展中的作用
Am J Pathol. 1997 Apr;150(4):1141-57.
3
Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.乙型肝炎X抗原在肝癌发生过程中上调血管内皮生长因子受体3。
Hepatology. 2007 Jun;45(6):1390-9. doi: 10.1002/hep.21610.
4
Hepatitis B x antigen and p53 in the development of hepatocellular carcinoma.乙型肝炎X抗原与p53在肝细胞癌发生发展中的作用
J Hepatobiliary Pancreat Surg. 1998;5(4):367-74. doi: 10.1007/s005340050060.
5
[The effects of p38MAPK and HBxAg on cell proliferation and apoptosis in human hepatocarcinogenesis].[p38丝裂原活化蛋白激酶和乙肝病毒X抗原在人类肝癌发生中对细胞增殖和凋亡的影响]
Zhonghua Gan Zang Bing Za Zhi. 2012 Mar;20(3):227-30. doi: 10.3760/cma.j.issn.1007-3418.2012.03.018.
6
Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma.乙型肝炎病毒X抗原在肝癌中对E-钙黏蛋白的下调作用
Oncogene. 2006 Feb 16;25(7):1008-17. doi: 10.1038/sj.onc.1209138.
7
[Correlation of hepatitis B virus X antigen expression with liver cell apoptosis].[乙型肝炎病毒X抗原表达与肝细胞凋亡的相关性]
Zhonghua Gan Zang Bing Za Zhi. 2013 Apr;21(4):252-6. doi: 10.3760/cma.j.issn.1007-3418.2013.04.004.
8
Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer.乙肝病毒携带者肝癌患者中的乙肝X抗原
Cancer Res. 1991 Sep 15;51(18):4971-7.
9
Overexpression of HBxAg in hepatocellular carcinoma and its relationship with Fas/FasL system.HBxAg在肝细胞癌中的过表达及其与Fas/FasL系统的关系。
World J Gastroenterol. 2003 Dec;9(12):2671-5. doi: 10.3748/wjg.v9.i12.2671.
10
Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.乙肝X抗原刺激一种新型细胞基因URG4的表达,该基因可促进肝细胞的生长和存活。
Neoplasia. 2002 Jul-Aug;4(4):355-68. doi: 10.1038/sj.neo.7900241.

引用本文的文献

1
lncRNA-HEIM Facilitated Liver Fibrosis by Up-Regulating TGF- Expression in Long-Term Outcome of Chronic Hepatitis B.lncRNA-HEIM 通过上调 TGF-β 表达促进慢性乙型肝炎的长期转归中的肝纤维化。
Front Immunol. 2021 Jun 8;12:666370. doi: 10.3389/fimmu.2021.666370. eCollection 2021.
2
An Study on the Role of Hepatitis B Virus X Protein C-Terminal Truncation in Liver Disease Development.乙型肝炎病毒X蛋白C末端截短在肝病发展中作用的研究
Front Genet. 2021 Mar 12;12:633341. doi: 10.3389/fgene.2021.633341. eCollection 2021.
3
Survivin expression starts before hepatocellular cancer development in the liver of chronic hepatitis B patients: a pilot, cross-sectional study.
生存素表达在慢性乙型肝炎患者肝脏发生肝细胞癌之前就已开始:一项前瞻性横断面研究。
Prz Gastroenterol. 2020;15(2):138-143. doi: 10.5114/pg.2019.87081. Epub 2019 Aug 8.
4
Targeting multiple oncogenic pathways for the treatment of hepatocellular carcinoma.针对肝细胞癌的多个致癌途径进行治疗。
Target Oncol. 2017 Feb;12(1):1-10. doi: 10.1007/s11523-016-0452-7.
5
Genetic variation of hepatitis B virus and its significance for pathogenesis.乙型肝炎病毒的基因变异及其在发病机制中的意义。
World J Gastroenterol. 2016 Jan 7;22(1):126-44. doi: 10.3748/wjg.v22.i1.126.
6
Human viral oncogenesis: a cancer hallmarks analysis.人类病毒致癌作用:癌症特征分析。
Cell Host Microbe. 2014 Mar 12;15(3):266-82. doi: 10.1016/j.chom.2014.02.011.
7
Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection.鉴定 cyclin B1 和 Sec62 作为乙型肝炎病毒相关肝细胞癌患者手术后复发的生物标志物。
Mol Cancer. 2012 Jun 8;11:39. doi: 10.1186/1476-4598-11-39.
8
Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation.人类肝细胞癌中的基因缺失和扩增:与肝细胞生长调控的相关性。
Am J Pathol. 2012 Apr;180(4):1495-508. doi: 10.1016/j.ajpath.2011.12.021. Epub 2012 Feb 8.
9
Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B.肝细胞癌患者与慢性乙型肝炎患者之间乙肝X基因突变的比较。
Virus Genes. 2011 Apr;42(2):162-70. doi: 10.1007/s11262-010-0557-5. Epub 2010 Dec 16.
10
Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.乙型肝炎X抗原在慢性肝病发病机制中的假定作用。
Cancer Lett. 2009 Dec 1;286(1):69-79. doi: 10.1016/j.canlet.2008.12.010. Epub 2009 Feb 6.